Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

HNX:MKV Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Apr 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019
Market Capitalization	90,000	75,500	49,000	54,000	55,000	60,000
Market Cap Growth	87.50%	54.08%	-9.26%	-1.82%	-8.33%	-14.29%
Enterprise Value	51,092	39,015	33,097	94,004	95,004	91,367
Last Close Price	18000.00	15100.00	9800.00	10800.00	10707.96	11681.42
PE Ratio	5.63	4.47	6.69	8.71	9.32	33.95
PS Ratio	0.59	0.50	0.46	0.49	0.46	0.59
PB Ratio	0.86	0.73	0.56	0.68	0.75	1.13
P/TBV Ratio	0.86	0.73	0.56	0.68	0.75	1.13
P/FCF Ratio	3.81	3.86	8.76	2.21	7.82	2.74
P/OCF Ratio	3.45	3.55	8.76	2.13	7.24	2.74
EV/Sales Ratio	0.34	0.26	0.31	0.85	0.79	0.89
EV/EBITDA Ratio	1.87	1.36	2.03	5.26	4.81	5.48
EV/EBIT Ratio	2.21	1.59	2.74	8.79	7.96	11.26
EV/FCF Ratio	2.16	1.99	5.91	3.85	13.51	4.17
Debt / Equity Ratio	-	-	-	-	0.25	0.79
Debt / EBITDA Ratio	-	-	-	-	0.93	2.51
Debt / FCF Ratio	-	-	-	-	2.62	1.91
Net Debt / Equity Ratio	-0.37	-0.31	-0.24	-0.19	0.11	0.76
Net Debt / EBITDA Ratio	-1.42	-1.13	-1.30	-0.85	0.42	2.40
Net Debt / FCF Ratio	-1.65	-1.66	-3.78	-0.62	1.17	1.83
Asset Turnover	1.32	1.33	1.03	1.09	-	0.88
Inventory Turnover	5.29	5.57	4.80	3.78	-	5.25
Quick Ratio	5.13	4.85	2.66	2.61	1.10	0.70
Current Ratio	6.77	7.29	3.45	3.35	2.10	1.08
Return on Equity (ROE)	16.46%	17.67%	8.77%	8.08%	-	3.38%
Return on Assets (ROA)	12.52%	13.60%	7.25%	6.54%	-	4.35%
Return on Invested Capital (ROIC)	26.82%	28.54%	14.71%	11.68%	10.75%	5.77%
Return on Capital Employed (ROCE)	22.00%	23.60%	13.80%	13.40%	15.90%	11.90%
Earnings Yield	17.76%	22.37%	14.95%	11.48%	10.73%	2.94%
FCF Yield	26.24%	25.92%	11.42%	45.20%	12.78%	36.51%
Payout Ratio	-	-	-	24.19%	-	-
Buyback Yield / Dilution	-	-	-	-0.02%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.